ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2697

Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia

Jayanth Doss1, Huan Mo2, Leslie J. Crofford1 and Joshua C. Denny2, 1Rheumatology, Vanderbilt University School of Medicine, Nashville, TN, 2Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Electronic Health Record, fibromyalgia, phenotypes, rheumatoid arthritis (RA) and serologic tests

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The differences between seronegative and seropositive rheumatoid
arthritis (RA) have not been widely reported. We performed an electronic health
record (EHR)-based phenome-wide association study (PheWAS) to identify disease associations
that differ between seropositive and seronegative RA.

Methods:   A validated algorithm identified RA subjects from the
de-identified EHR (1). Serotypes were determined by values of rheumatoid factor
(RF) and anti-cyclic citrullinated peptide antibody (ACPA). A PheWAS uses
logistic regression to identify ICD9 codes that are more likely to be present
in one group of patients versus another. A PheWAS comparing seropositive and
seronegative patients was performed and identified disease associations (i.e.
ICD9 codes) for each serotype. Following PheWAS, select disease associations
were manually reviewed and fibromyalgia was specifically evaluated using a
validated algorithm.

Results:   A total of 2199 individuals were identified with RA and with
serologic testing. Of these, 1382 (63%) were seropositive. Seronegative RA was
associated with “Myalgia and Myositis” (odds ratio [OR] 2.1, P=3.7×10-10)
and back pain. A manual record review showed 80% of Myalgia and Myositis codes
were used for fibromyalgia, and follow-up with a specific EHR algorithm for
fibromyalgia confirmed that seronegative RA was associated with fibromyalgia (OR=1.8,
P=4.0×10-6). Seropositive RA was associated with Chronic Airway
Obstruction (OR=2.2, P=1.4×10-4), tobacco use (OR=2.1, P=3.8×10-4),
and other pulmonary phenotypes.

Conclusion:   This PheWAS study in RA patients identifies a strong
association between seronegativity and fibromyalgia.  It also replicates a
well-known association between seropositivity and chronic airway obstruction
related to tobacco use. These findings demonstrate the utility of the PheWAS
approach to discover novel phenotype associations within different subgroups of
a disease.

Table 1

 

All Patients (n = 2199)

Seropositive (n = 1382)

Seronegative (n = 817)

Demographic Characteristics

 

 

 

Age, mean ± SD years

52.1 ± 14.5

53.17 ± 13.4

51.7 ± 14

Sex, no. (%) female

1669 (76)

1012 (73)

657 (80)

Race, no. (%)

 

 

 

White

1711 (78)

1063 (77)

648 (79)

Black

176 (8)

127 (9)

50 (6)

Other

22 (1)

14 (1)

7 (1)

Unknown

290 (13)

178 (13)

112 (14)

Electronic Health Record (EHR) Encounter Data

 

 

 

Median EHR time in years (IQR)

8 (5 – 14)

8 (5 – 13)

8 (5 – 14)

Median EHR time with RA ICD9 Codes in years (IQR)

6 (3 – 8)

6 (3 – 9)

5 (3 – 8)

Median EHR Billing Encounters (IQR)

29 (14 – 60)

29 (14 – 60)

29 (14 – 60)

Median EHR Billing Encounters with RA ICD9 Codes (IQR)

16 (8 – 28)

17 (8 – 29)

14 (7 – 26)

 

 

Table 2. PheWAS results adjusted for age and sex

 

Cases

Controls

OR

CI (95%)

p

Associations favoring seronegative RA 

Myalgia and Myositis *

346

1642

2.1

1.7 – 2.7

3.7 x 10-10

Spondylosis and allied disorders

104

1725

2.2

1.4 – 3.2

1.7 x 10-4

Spondylosis without myelopathy

96

1725

2.2

1.4 – 3.3

2.5 x 10-4

Intervertebral disc disorders

191

1725

1.7

1.3 – 2.3

5.2 x 10-4

Internal Derangement of Knee

38

2032

3.4

1.7 – 6.8

5.3 x 10-4

Polymyalgia Rheumatica

35

2140

3.2

1.6 – 6.6

1.1 x 10-3

Spinal Stenosis

102

1725

1.9

1.3 – 2.9

1.7 x 10-3

 

 

 

 

 

 

Associations favoring seropositive RA

Chronic Airway Obstruction

149

1842

2.2

1.5 – 3.4

1.4 x 10-4

Tobacco Use Disorder

143

1885

2.1

1.4 – 3.1

3.8 x 10-4

Staphylococcus Infection

32

2051

5.7

1.7 – 18.8

4.3 x 10-3

Chronic Ulcer of Skin

51

2104

2.8

1.3 – 5.8

5.8 x 10-3

Diseases of Respiratory System

29

2112

7.5

1.8 – 31.6

6.2 x 10-3

Post-Inflammatory Pulm Fibrosis

65

1880

2.4

1.3 – 4.4

6.3 x 10-3

Symptoms Involving Resp System

26

2138

6.6

1.6 – 28.1

1.1 x 10-2

* p-value reaches Bonferroni
threshold of 1.3 x 10-4

 

Figure 1.  PheWAS Manhattan
plots of RA patients comparing seropositive and seronegative phenotypes


 

References

1.    Carroll
RJ, et al. Portability of an algorithm to identify rheumatoid arthritis in
electronic health records. J Am Med Inform Assoc JAMIA. 2012 Jun;19(e1):e162–9.


Disclosure: J. Doss, None; H. Mo, None; L. J. Crofford, None; J. C. Denny, None.

To cite this abstract in AMA style:

Doss J, Mo H, Crofford LJ, Denny JC. Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/phenome-wide-association-study-of-rheumatoid-arthritis-subgroups-identifies-association-between-seronegative-disease-and-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/phenome-wide-association-study-of-rheumatoid-arthritis-subgroups-identifies-association-between-seronegative-disease-and-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology